Forty-five years have elapsed since Hench comprehensively detailed the stages of gouty arthritis and admonished 'it is the suspicion of gout, unfortunately, not the disease which has disappeared'.' The clinical presentation of acute monoarticular gout and extensive, deforming chronic tophaceous gout are well described`-3 and readily recognised. However, acute polyarticular gout may be confusing clinically because the features are less familiar.`7 Effective hypouricaemic therapy became available first with probenecid in 19508 and then with allopurinol in 1963.9 Therefore acute polyarticular gout, indicative of more severe or uncontrolled gout,6 should now be a medical curiosity rarely seen by a consulting rheumatologist. Nevertheless in a 3-year period we saw 41 cases of acute polyarticular gout at the Minneapolis VA Medical Center. Nearly half of these patients were not diagnosed initially as gouty arthritis. The purpose of this study is to characterise the masquerade of acute polyarticular gout in order to increase suspicion for this entity. During the treatment and follow-up of these patients we also encountered several important problems which are discussed. Precipitating factors described previously were common in our patients with acute gout.1-3 Severe medical illness was present in 9 patients (see Table  5 ). Five patients developed acute polyarticular gout 2-4 days postoperatively. Changes in medication within 2 weeks of the attack were noted in 11 patients. The medication changes included: institution of diuretics in one case, institution or cessation of hypouricaemic drugs in 4 cases, and cessation of anti-inflammatory drugs in 6 cases. Overall 25 of the patients had one or more of these antecedent events prior to the attack of polyarticular gout.
ARTICULAR INVOLVEMENT
The total number of joints involved was 159, with a mean of 3.9 joints per patient ( Table 6 ). The majority of patients (71 %) had acute inflammation in 3 or more joints. Joint inflammation was limited to the lower extremities in 56 % of the patients, to the upper extremities in 7%, and involved both upper and lower extremities in 37%. The most common joint involved was the first metatarsal phalangeal joint, followed by the ankle and knee (Table 7) . Foot or ankle joint inflammation was present in 88% of the patients.
LABORATORY ABNORMALITIES
Serum uric acid measured in 37 patients at the time of the acute attack ( 12 % of these patients, which is lower than the 27 to 44% previously reported.24 5 There was a history of intermittent acute arthritis highly suggestive of gout in 85 %, prior polyarticular attacks in 66 %, and documented hyperuricaemia in 56%. Tophi were present in 39%. All 19 cases not initially recognised as gout had one or more of these clues in the medical history to suggest the diagnosis.
Fever, leucocytosis, and normouricaemia were present in nearly half of the patients. However, there was no correlation between these factors and the observed diagnostic confusion.
We noted 2 different modes of onset in this group of patients. The arthritis was more fulminant in the 'simultaneous onset' patients than in the 'additive onset' group, but there were no differences in degree of hyperuricaemia, fever, leucocytosis, incidence of tophi, or therapeutic outcome. The mode of onset did not appear to influence the recognition of acute polyarticular gout.
As has been previously noted, the distribution of joint involvement was asymmetrical in most cases.'`6
In contrast to previous reports of proved polyarticular gout4 the foot and ankle joints were spared in only 12 % of our patients. These patients responded promptly to antiinflammatory therapy. Fever decreased within 4 
